General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novartis(MODEST) RESEARCH/RESEARCH GRANTS: Novartis Corporation(SIGNIFICANT), Novo Nordisk(SIGNIFICANT), Esperion(SIGNIFICANT), Gilead(SIGNIFICANT)

View Full Disclosure